A61K 36/074
Ganoderma
A61K36/074 (Ganoderma) appears on 169 US grants and 329 published applications in this corpus.
Search patents in A61K- Granted patents
- 169
- Published applications
- 329
- Assignees
- 179
- Inventors
- 630
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 2 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 1 |
| 2002 | 7 | 9 |
| 2003 | 3 | 14 |
| 2004 | 9 | 9 |
| 2005 | 5 | 17 |
| 2006 | 4 | 8 |
| 2007 | 2 | 10 |
| 2008 | 6 | 17 |
| 2009 | 7 | 11 |
| 2010 | 6 | 7 |
| 2011 | 3 | 9 |
| 2012 | 4 | 5 |
| 2013 | 1 | 13 |
| 2014 | 3 | 10 |
| 2015 | 5 | 18 |
| 2016 | 9 | 14 |
| 2017 | 9 | 13 |
| 2018 | 9 | 9 |
| 2019 | 8 | 17 |
| 2020 | 11 | 12 |
| 2021 | 12 | 16 |
| 2022 | 4 | 17 |
| 2023 | 9 | 15 |
| 2024 | 5 | 23 |
| 2025 | 8 | 19 |
| 2026 | 5 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Botanicals as WNT/beta-catenin activators, molecular pathway regulators, tissue regenerators and health biomarker regulators18 Aug 2026US 12,708,655 B2Arbor Life Holdings, Ltd.
- Agave syrup formulation or suspension for active pharmaceutical agents19 May 2026US 12,629,422 B2Genexa Inc.
- Ganoderma lucidum spore oil and use thereof in preparation of anti-cancer-related fatigue medicaments12 May 2026US 12,622,939 B2Guangzhou Hanfang Pharmaceutical Co., Ltd.
- Combined fungal composition for modulating an inflammatory response12 May 2026US 12,622,940 B2Turtle Bear Holdings, LLC
- Supplement compositions24 Feb 2026US 12,558,390 B2
- Mushroom blend for increasing butyrate production in the gut biome8 Oct 2026US 2026/0306567 A1AMI Newco LLC
- Use of ginsenoside in combination with pd-1 blocker in preparing medicament against head and neck squamous cell carcinoma3 Sep 2026US 2026/0256821 A1Chinese Academy of Medical Sciences Institute of Medicinal Plant Development
- Composition for synergistic relief of physical fatigue and its application27 Aug 2026US 2026/0248868 A1Xianghu Laboratory (Zhejiang Provincial Laboratory of Agriculture)
- Combined fungal composition for modulating an inflammatory response20 Aug 2026US 2026/0240930 A1Turtle Bear Holdings, LLC
- Nutraceutical mushroom compositions and methods of treatments using same30 Jul 2026US 2026/0216268 A1Mangoceuticals, Inc.
Most cited
By later US patents
- Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression64US 5,589,182 A1996
- Dosage form52US 7,608,270 B2University of Hull · 2009
- Herbal remedies for treating allergies and asthma48US 6,630,176 B2Mount Sinai School of Medicine of New York University · 2003
- Method and synergistic composition for treating attention deficit/hyperactivity disorder46US 6,541,043 B2DexGen Pharmaceuticals, Inc. · 2003
- Pharmaceutical composition comprising Cannabinoids27US 8,642,645 B2Brooks Kelly Research, LLC · 2014